Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1402201000168112 | aminolevulinic acid hydrochloride 30 mg / 1 mL powder for oral liquid, 1.5 g (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1402211000168110 | aminolevulinic acid hydrochloride 30 mg/mL powder for oral liquid, 1.5 g | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| aminolevulinic acid hydrochloride 30 mg/mL powder for oral liquid, 1.5 g | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| aminolevulinic acid hydrochloride 30 mg/mL powder for oral liquid, 1.5 g | has MPUU | aminolevulinic acid hydrochloride 30 mg/mL powder for oral liquid | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gliolan 30 mg/mL powder for oral liquid, 1.5 g | Is a | False | aminolevulinic acid hydrochloride 30 mg/mL powder for oral liquid, 1.5 g | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR